Dutch scientists track virus response to new COVID drugs
NCT ID NCT05195060
Summary
This study observed over 1,100 adult patients in the Netherlands who received new COVID-19 treatments like monoclonal antibodies or antiviral pills as part of their standard care. Researchers collected blood and swab samples to track how the virus and the patient's immune system responded during and after treatment. The goal was to understand how well these drugs work in real-world settings, which patients benefit most, and to monitor for safety and new virus variants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amsterdam University Medical Centre
Amsterdam, North Holland, 1105 AZ, Netherlands
-
Amsterdam University Medical centre - VUMC
Amsterdam, North Holland, 1081 HV, Netherlands
-
Leiden universitair medisch centrum
Leiden, 2333ZA, Netherlands
-
Radboud Universitair Medisch Centrum
Nijmegen, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.